RAPP
Rapport Therapeutics, Inc. Common Stock · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +12.5% ·
flujo de acciones +3.6% ·
nuevas posiciones netas +11.1%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 69 | +3 | 25.15M | $1.04B | +5 | −2 |
| Q1 2026 | 69 | +1 | 25.07M | $783.61M | +5 | −4 |
| Q4 2025 | 68 | +1 | 25.43M | $771.51M | +1 | — |
| Q3 2025 | 16 | +4 | 15.68M | $465.84M | +4 | — |
| Q2 2025 | 9 | +1 | 10.01M | $113.83M | +2 | −1 |
| Q1 2025 | 5 | 0 | 1.86M | $18.69M | +1 | −1 |
| Q4 2024 | 5 | 0 | 2.06M | $36.50M | — | — |
| Q3 2024 | 4 | -2 | 1.81M | $36.50M | +1 | −3 |
| Q2 2024 | 6 | — | 2.18M | $50.21M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 5.47M | — | $62.25M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 5.47M | — | $62.25M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.53M | +42.1% | $17.35M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.53M | +42.1% | $17.35M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 1.22M | — | $13.86M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 1.22M | — | $13.86M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 1.22M | — | $13.86M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 1.22M | — | $13.86M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 1.22M | — | $13.86M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 1.22M | — | $13.86M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 1.22M | — | $13.86M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (pasivo) | 1.11M | — | $12.59M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (pasivo) | 1.11M | — | $12.59M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (pasivo) | 1.11M | — | $12.59M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Geode Capital Management ✦ (pasivo) | 333.16K | +5.5% | $3.79M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Geode Capital Management ✦ (pasivo) | 333.16K | +5.5% | $3.79M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (pasivo) | 298.71K | +56.3% | $3.40M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 19.74K | -41.5% | $224,478 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 16.97K | Nuevo | $192,971 | 0.0% | New | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 16.97K | Nuevo | $192,971 | 0.0% | New | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 16.97K | Nuevo | $192,971 | 0.0% | New | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 16.97K | Nuevo | $192,971 | 0.0% | New | 1 | SEC ↗ |
| 23 | Renaissance Technologies ✦ | 15.60K | Nuevo | $177,372 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| AQR Capital Management | $192,971 | 0.0% |
| AQR Capital Management | $192,971 | 0.0% |
| AQR Capital Management | $192,971 | 0.0% |
| AQR Capital Management | $192,971 | 0.0% |
| Renaissance Technologies | $177,372 | 0.0% |
Posición cerrada
| Citadel Advisors | $2.50M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 146 tenedores, 52.47M acciones, $1.59B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 404 acc. · $20,160
Officer, Director · 3.66K acc. · $171,837
Officer, Director · 19.50K acc. · $936,846
Officer, Director · 5.79K acc. · $281,721
Officer, Director · 14.17K acc. · $651,492
Officer, Director · 8.37K acc. · $391,280
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología